## PSKY: Paramount Skydance Corporation - XLC: Communication Services

### Executive Summary

VALUE thesis: PEG 0.84 indicates fundamental undervaluation.

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($13.00)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Morgan Stanley raises Paramount Skydance stock price target to $12 on new ownership strategy**
- Source: Investing.com | 20251209T124047 | Neutral | Relevance: 99%
-  Morgan Stanley increased its price target for Paramount Skydance (NASDAQ:PSKY) to $12.00 from $10.00, while maintaining an "Underweight" rating. The firm acknowledged the new ownership's strategy to revitalize Paramount, despite the company's revenue decline and significant enterprise value. Concerns remain about the valuation and the stock's risk-reward profile, particularly in light of ongoing acquisition bids for Warner Bros. Discovery.

**2. Warner Bros. bidding war: Paramount & Netflix offers compared**
- Source: Yahoo Finance | 20251208T123000 | Somewhat-Bullish | Relevance: 93%
-  Paramount Skydance has made an all-cash hostile bid to acquire Warner Bros. Discovery for $30 per share, challenging Netflix's prior deal for only the studio and streaming units. This development creates a bidding war, with analysts comparing the offers and their potential benefits for Warner Bros. Discovery, while also noting concerns about financing and regulatory approval for the Paramount bid.

**3. Stocks making the biggest moves midday: Paramount Skydance, Wave Lifesciences, Confluent & more**
- Source: CNBC | 20251208T123500 | Bullish | Relevance: 92%
- Several companies experienced significant stock movements midday. Wave Life Sciences more than doubled after positive interim data for its obesity shot. Paramount Skydance rose following its hostile bid for Warner Bros. Discovery, while Confluent shares surged on news of a potential $11 billion acquisition by IBM.

**4. Ellison's Paramount makes $108B cash offer for Warner Bros. Discovery, escalating buyout fight with Netflix**
- Source: Yahoo Finance | 20251208T160834 | Somewhat-Bullish | Relevance: 91%
-  Paramount, led by David Ellison, has made an all-cash offer of $108.4 billion for Warner Bros. Discovery, challenging Netflix's prior $72 billion bid. This new offer aims to acquire all of Warner Bros.' assets, unlike the Netflix deal which only includes its TV, film, studios, and streaming division. Paramount's bid simplifies financing through increased equity commitments from the Ellison family and RedBird Capital, and seeks to avoid the extensive regulatory scrutiny anticipated for a combined Netflix-WBD entity.

**5. Paramount and Warner Bros.: Hostile Bid Is Probably Superior to Netflix’s, but Not Clearly**
- Source: Morningstar | 20251208T200926 | Somewhat-Bullish | Relevance: 87%
-  Paramount's hostile bid of $30 per share for Warner Bros. Discovery is seen as potentially superior to Netflix's $27.75 cash and stock offer, primarily due to the certainty of the cash component and lower anticipated international regulatory scrutiny. While both bids value Warner above its independent worth and could lead to a bidding war, the author believes a Paramount acquisition offers better benefits for its shareholders than a Netflix acquisition. Morningstar maintains a $77 fair value estimate for Netflix and a $20 fair value estimate for Paramount, with plans to raise Warner's fair value to $28 if an acquisition occurs by early 2027.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 6, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Morgan Stanley | $12 | $10 | +20% |
| 2025-11-12 | Guggenheim | $16 | $0 | 0% |
| 2025-11-12 | Bernstein | $12 | $11 | +9% |
| 2025-11-11 | Evercore ISI Gr | $14 | $12 | +17% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Morgan Stanley | main | Underweight |
| 2025-11-12 | Guggenheim | reit | Neutral |
| 2025-11-12 | Bernstein | main | Underperform |
| 2025-11-11 | Evercore ISI Gr | main | In-Line |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Lingotto Investment : 8.8% (+100.0%)
- Vanguard Group Inc: 3.4% (+100.0%)
- State Street Corpora: 2.6% (+100.0%)
- Blackrock Inc.: 1.6% (+100.0%)
- Kohlberg Kravis Robe: 1.5% (+100.0%)

### Key Risks

1. Near-term weakness: 10.0% below SMA50 despite long-term uptrend.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 6 raises (avg +16%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.84 indicates undervaluation relative to growth. Forward P/E 14.1x attractive for 51% earnings growth. Analyst sentiment positive (6 raises, avg +16%). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $16.2B |
| Beta | 1.18 |
| 52W Range | $9.95 - $20.86 |
| Short Interest | 5.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.84 |
| Forward P/E | 14.1 |
| Current P/E | 21.3 |
| YoY Growth | 50.7% |
| EPS Direction | FALLING |

### Technicals

MRS_20 stable at -7.1% (minimal 5-day change). Below STRENGTH zone by 11.1pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.4%) - potential reversal signal. AM_20 at -5.0% indicates price below own 20MA trend. Underperforming sector by 7.3pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). RSI neutral at 44. Elevated volume (2.9x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -7.12% (CS: 6) | Weak |
| RSI_14 | 43.9 | Neutral |
| MACD Histogram | -0.10 | Bearish |
| vs SMA20 | 0.950x | Below |
| vs SMA50 | 0.900x | Below |
| vs SMA200 | 1.066x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $14.64
- **Stop Loss:** $13.00 (11.2% risk)
- **Target:** $17.92 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 609
- **Position Value:** $8,915.76
- **Portfolio %:** 8.92%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-26 (Est: $-0.03)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $-0.12 | -129.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*